Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Item
http://www.wikidata.org/entity/Q34566047
Ocular itch associated with allergic conjunctivitis: latest evidence and clinical managementUpdate and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitisPooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitisOcular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials.A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model.Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief.
P2860

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

Item
http://www.wikidata.org/entity/Q34566047
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@ast
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@en
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@nl
type
label
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@ast
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@en
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@nl
prefLabel
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@ast
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@en
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932
P356
P1433
P1476
Evaluation of alcaftadine 0.25 ...... placebo and olopatadine 0.1%.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P921
P932